Loading...
Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome
Myelodysplastic syndrome (MDS) is an aggressive and genetically heterogeneous disease with poor prognosis. Cellular immune disorder is a common characteristic of this disease and is thought to be related to clinical outcome. Alterations in T cell clonal expansion and T cell dysfunction has been dete...
Na minha lista:
| Udgivet i: | Biomark Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8193904/ https://ncbi.nlm.nih.gov/pubmed/34112264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00302-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|